The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Stage at diagnosis and early mortality from cancer in England
Open accessAbstract
BACKGROUND: Stage at diagnosis is a key predictor of overall cancer outcome. For the first time, stage completeness is high enough for robust analysis for the whole of England. METHODS: We analysed data from the National Cancer Registration Service's (NCRS) Cancer Analysis System on persons diagnosed with breast, colorectal, lung, prostate or ovarian cancers in England in 2012. One-year relative survival (followed-up to the end of 2013) was calculated along with adjusted excess rate ratios, for mortality within 1 year. RESULTS: One-year relative survival decreased with increasing stage at diagnosis. For breast, prostate and colorectal cancers survival showed a major reduction for stage 4 cancers, whereas for lung and ovarian cancers there were substantial decreases in relative survival for each level of increase in stage. Excess rate ratios for mortality within 1 year of diagnosis showed that stage and age were the most important cofactors, but they also identified the statistically significant effects of sex, income deprivation and geographic area of residence. CONCLUSIONS: Further reductions in mortality may be most effectively achieved by diagnosing all cancers before they progress to stage 4, but for lung and ovarian cancers there is also a need for a stage shift to earlier stages together with efforts to improve stage-specific survival at all stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standard cancer patient population for age standardising survival ratios
Corazziari, I., Quinn, M., & Capocaccia, R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.002 · Cited by 589 · cited 2×
“Age-standardised relative survival was calculated using a method of Corazziari et al, 2004.”
BackgroundMethodWhat if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman, M., Stockton, D., Rachet, B., Hakulinen, T., & Coleman, M. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605401 · Cited by 160
Cited by
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
Cheng, T.-Y. D., Cramb, S. M., Baade, P. D., Youlden, D. R., Nwogu, C., & Reid, M. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.021 · Cited by 600
White, A., Ironmonger, L., Steele, R. J. C., Ormiston-Smith, N., Crawford, C., & Seims, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4786-7 · Cited by 405
The Role of Artificial Intelligence in Early Cancer Diagnosis
Hunter, B., Hindocha, S., & Lee, R. W. (2022) · Cancers · doi:10.3390/cancers14061524 · Cited by 332
Knight, S. R., Shaw, C. A., Pius, R., Drake, T. M., Norman, L., Ademuyiwa, A. O., Adisa, A. O., Aguilera, M. L., Al-Saqqa, S. W., Al-Slaibi, I., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00001-5 · Cited by 328
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Schøler, L. V., Reinert, T., Ørntoft, M.-B. W., Kassentoft, C. G., Árnadóttir, S. S., Vang, S., Nordentoft, I., Knudsen, M., Lamy, P., Andreasen, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0510 · Cited by 306
Metadata
- Authors
- McPhail, S., Johnson, S., Greenberg, D., Peake, M., & Rous, B.
- Venue
- British Journal of Cancer
- Published
- 2015-03
- Volume
- 112
- Issue
- S1
- Pages
- S108-S115
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1985530355
- Cited by
- 295
- References
- 2
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stage at diagnosis and early mortality from cancer in England. https://app.cochat.ai/papers/10.1038/bjc.2015.49
- The paper
- McPhail, S., Johnson, S., Greenberg, D., Peake, M., & Rous, B. (2015). Stage at diagnosis and early mortality from cancer in England. British Journal of Cancer. https://doi.org/10.1038/bjc.2015.49
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.